





Background: Out-of-hospital cardiac arrest (OHCA) is the sudden cessation of the heart in an out of hospital setting. In the United States, the incidence of OHCA is estimated at 110 individuals per 100,000 per year with an overall survival rate of 5.2%. The American Heart Association guidelines recommends angiography for patients who have ST elevation in electrocardiogram followed by proper treatments. In patients without ST elevation, other general tests and observations would be conducted before further interventions. Some evidence suggests that immediate angiography and appropriate intervention for OHCA patients could result in better healthcare outcomes regardless of the presence of ST elevation in electrocardiogram. The goal of this study is to investigate whether immediate angiography and PCI are cost-effective compared to the standard of care.
Methods: We built a decision tree in TreeAge Pro Software to compare the cost-effectiveness of immediate angiography followed by proper interventions to standard care.  The model calculates the costs and benefits of each strategy over a short-term period.  We reviewed the literature to obtain the model parameters, including probabilities for choosing interventions, intervention costs, quality of life and life expectancy estimates. We calculated incremental cost-effectiveness ratio of immediate angiography strategy compared to standard of care. In addition, we tested the robustness of our outcomes using Tornado analysis, and probabilistic sensitivity analysis (PSA) in which we varied all the parameters jointly. 
Results: Immediate angiography was less expensive than the standard care ($1,281) per patient treated per year, and more effective [0.03 quality-adjusted life-years (QALYs)]. These findings were robust to all one-way sensitivity analyses. In addition, PSA showed there is more than 91% chance that immediate angiography is more cost effective than the standard care conditional on $100,000/QALY willingness to pay threshold.
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Out-of-hospital cardiac arrest (OHCA) is defined as the sudden cessation of the heart in out-of-hospital setting. OHCA is a leading global cause of death, in the US. Each year around 400,000 people experience non-traumatic OHCA assessed by emergency medical services (EMS) with a 5.2 % survival overall and this number has been increasing from 2011 to 2014. ADDIN EN.CITE 1 In the United States, the incidence rate per emergency medical service (EMS) has been estimated around 110.8 individuals per 100,000 population. ADDIN EN.CITE 2 The overall survival to hospital discharge is around 10.8% and the median age for OHCA is around 65 years.3 Improving the survival and health care outcomes of these patients is important when considering management strategies. 
According to the OHCA surveillance, in about 78.7% of OHCA patients the cause is due to no obvious extra-cardiac reasons, for example, ventricular fibrillation (VF), pulseless ventricular tachycardia, asystole or pulseless electric activity. Among them, acute myocardial infarction (MI) and VF have been major causes. ADDIN EN.CITE 4,5 The high mortality of out-of-hospital cardiac arrest highlights the importance of identifying the risk factors. However, There are also factors that are not know well. Since coronary disease is the main cause for OHCA, cardiovascular risk factors could increase the risk of having OHCA. For example, smoking and diabetes can significantly increase the risk of suffering OHCA. ADDIN EN.CITE 6,7 Brain-related issues are other causes of OHCA. Arnaout et al. ADDIN EN.CITE 8 performed a retrospective review (1999-2012) of adults with a primary neurologic cause of OHCA and compared two randomly selected groups of patients with OHCA of non-neurologic etiology. Among the patients they studied, 2.3% suffered OHCA from brain-related etiology and most of the patients had OHCA caused by subarachnoid hemorrhage (SAH). All patients died within three days. Patients with brain-related causes are not covered by our research but it is very important to exclude these patients from the model because they should receive different treatment from patients with cardiac causes.
Acute myocardial infarction (MI) is one of the major causes of OHCA and there are two major types of MI, ST-segment elevation myocardial infarction (STEMI) and Non-ST-segment elevation myocardial infarction (NSTEMI). The formation of blood clots in the major coronary arteries previously affected by atherosclerosis can result in STEMI, which main mechanism of atherosclerosis is cholesterol deposition within the artery wall.9 The deposited cholesterol eventually forms a plaque called atherosclerosis plaque. In a long-term process, the atherosclerosis plaque may develop into blood clots and finally block the coronary artery and interrupt the blood supply, ultimately, leading to a ST-segment elevation myocardial infarction.
The pathophysiology of NSTEMI is different from STEMI. In STEMI, a complete occlusion could develop in a major artery that is previously affected by atherosclerosis and lead to necrosis or death of the entire thickness of the myocardium, known as transmural infarction, downstream from the blockage. While, NSTEMI results from a complete occlusion developed in a minor coronary artery or a partial occlusion developed in a major coronary artery that is previously affected by atherosclerosis.  In this case transmural infarction is not evident per ECG findings and the myocardium may have partial necrosis.10 Usually, the ECG findings of NSTEMI are T-wave inversion or ST-depression without showing ST-segment elevation. On the other hand, STEMI shows ST-segment elevation plus pathological Q-wave formation and T-wave inversion in ECG.11

The 2010 American Heart Association (AHA) guideline has introduced general strategies for the diagnoses and treatments of cardiac-causes of OHCA, categorized by the presence of ST-segment elevation. ADDIN EN.CITE 12,13 These guidelines suggest immediate angiography for patients who have ST-segment elevation on electrocardiogram (ECG) followed by appropriate treatments, such as percutaneous coronary intervention (PCI), stenting or coronary artery bypass graft surgery (CABG). For patients without ST-segment elevation, these guidelines suggest other tests first, such as an echocardiogram and in-hospital observation. In the United States, health care practitioners are usually following these guidelines. Although the guidelines recommend the strategy of employing coronary angiography based on the results of the electrocardiogram (ECG), it is not confirmed whether the ECG are credible and reliable initial test. A recent review found that electrocardiogram after successful resuscitation is not quite helpful for defining coronary lesions.14
Recently, health care practitioners in emergency room and cardiologists are tending to use immediate angiography without considering ECG results. Dumas and his colleauges ADDIN EN.CITE 15 found that an immediate angiography could lead to better outcomes in survival and neurological functions regardless of the presence of ST-segment elevation in ECG for OHCA patients. Because of the high probability of occurrence of false negative ECG results, interventions could be delayed and the best treatment window could be missed for OHCA patients who do have culprit occlusions in vessels and can be more beneficial than ECG. Under these circumstances, the immediate angiography should be considered as a diagnosis tool.16 Although there is still some controversy, research supports that there is improved outcomes following immediate angiography in OHCA patients. ADDIN EN.CITE 14,17-19
	Milosevic et al20 compared immediate and delayed invasive interventions for non-STEMI patients and concluded that immediate angiography could lead to a better survival and neurological outcomes. However, up to now, no published literatures have reported cost-effectiveness analysis of immediate angiography for OHCA patients with no obvious extra-cardiac causes globally. Patients, healthcare practitioners, payers and policy makers would benefit from knowing whether the improvements in outcomes are worthy for the additional cost of immediate angiography.  Thus, our aim is to construct a decision analytic model to compare the cost-effectiveness of applying the new immediate angiography strategy versus the standard care management strategy initiated by ECG to treat patients with OHCA due to cardiac causes. We report our findings to provide important data that may assist in the decision of implementing immediate angiography for every patient resuscitated from OHCA.
2.0 	method
2.1	Decision analytical model
We built a decision-analytical model to compare the cost-effectiveness of immediate angiography plus appropriate interventions versus the standard care management strategy initiated by ECG for the patients who experienced out-of-hospital cardiac arrest (OHCA) in 1-year time horizon. We chose the short-term time horizon because 1-year survival rate is from 5% to 10% and most of the differences in cost and benefit occur in this period after hospitalization.14 We used the societal perspective when considering the cost and healthcare outcome of treatments. Patients with no obvious extra-cardiac causes were included in the model. However, patients with obvious extra-cardiac causes, such as respiratory failure, brain stroke, metabolic disorder, hemorrhage, or any other non-cardiac reasons, were excluded from the model as these patients would be treated following other procedures. We built the model in TreeAge 2017 software (Williamstown, Massachusetts) A schematic representation of the decision tree is shown in Figure 1.
2.2	Treatment strategies
Patients who were resuscitated from OHCA either receive 1) standard care, where patients would receive the electrocardiogram (ECG) followed by the regular angiography and proper interventions based on the results of ECG, or 2) immediate angiography, where every patient would receive an immediate angiography and proper interventions. In the standard care, patients will undergo emergency electrocardiogram (ECG) followed by angiography when it shows a ST-segment elevation. If the angiography result indicates that there are culprit lesions then invasive interventions like coronary artery bypass graft (CAGB) and percutaneous coronary intervention (PCI) will be implemented for patients with severe occlusions based on the angiographic results13. Patients with diabetes, hypertension or other conditions who are not eligible for PCI will undergo CABG. If ECG shows negative results or there isn’t any culprit lesion based on angiography, patients will receive conservative or medical treatment (MEDS). The procedure of medical treatment was defined through the research of Cannon and his colleagues. ADDIN EN.CITE 21 In the medical or conservative treatment, the catheterization would be performed only for those who experienced recurrent ischemia or had an abnormal stress test. Otherwise, patients would just receive conservative or medical treatments. 
In the strategy of immediate angiography, however, without implementing emergency ECG, an immediate angiography will be conducted for every patient who was resuscitated from OHCA. Based on the angiographic results, which shows the existence, locations and severity of occlusions, patients will be assigned into different intervention groups (PCI vs CABG vs MEDS) based on conditions described above. All patients would receive regular testing plus medicines and followed by routine physician visits during the treatment period.
Patients with less than 50% occlusion were considered to be at moderate risk and were assigned into MEDS group, while patients with equal to or more than 50% occlusion in vessels were considered to have a severe condition and were assigned into PCI or CABG group. In addition to the procedures indicated by these two strategies, patients would receive appropriate care according to the 2010 American Heart Association guidelines for CPR and ECC. ADDIN EN.CITE 12,13
2.3	Key assumptions











For both treatment strategies, our model calculated quality adjusted life expectancy (quality-adjusted life-years [QALY]) and cost in 1-year time horizon. We compared the performance of the two treatment strategies through the incremental cost-effectiveness ratio (ICER), defined as marginal cost divided by the marginal effectiveness, and incremental net monetary benefit (INMB), defined as difference in dollar value of healthcare outcomes. We conducted one-way sensitivity analyses for every variable in our model to assess the influences of them within a clinically plausible range on cost-effectiveness or net monetary benefit. We then plotted the tornado diagrams for every parameter. Additionally, we conducted probabilistic sensitivity analysis (PSA) through Monte Carlo simulation. The Monte Carlo simulation was run for 1,000 samples, where parameter values were randomly selected from assigned distributions. We assumed probabilities and QALY followed a Beta distribution and the cost of interventions followed a Log-normal distribution. A willingness-to-pay threshold of $100,000/QALY was chosen. This threshold is a commonly considered reasonable value used in other research.22 Parameters estimates
2.5	Parameter Estimate
The base case estimates and ranges of all parameters, quality adjusted life-year, and costs used in the model are summarized in Table 1. 
2.5.1	Probabilities
To estimate the parameters used in our model, we pooled data from the published literature with emphasis on randomized clinical trials and large population-based studies. ADDIN EN.CITE 15,23-26 In Dumas’ stduy ADDIN EN.CITE 15, 714 patients with OHCA were included and immediate coronary angiogram were introduced for 435 patients of them with no obvious extra-cardiac reason of cardiac arrest. 134 had ST-segment elevation and among the 134 patients with ST-segment elevation, 128 has ≥ 1 significant coronary lesions. 301 patients who did not have ST-segment elevation and among the 301 patients without ST-segment elevation, 176 has ≥ 1 significant coronary lesions. The probabilities of having successful PCI in the immediate angiography strategy was 58% and the probability of having successful PCI in the standard care strategy given patients having ECG ST-segment elevation was 74%. Because the trial was targeting the patients with out-of-hospital cardiac arrest, we used 50% occlusion in the vessel as the threshold to assign patients into different intervention groups and defined the presence of a culprit lesion as an angiographic acute-appearing coronary lesion. We derived the sensitivity of ECG ST-Elevation for diagnosing occlusions from Menown’s paper24 after comparison among different studies. Since the specificity of ECG ST-segment elevation for diagnosing artery occlusions is stable, we derived it from Dumas’ study. ADDIN EN.CITE 15
2.5.2	Quality Adjusted Life-Years
Quality-of-life weight is also called utility score, which has a range from 0 to 1, in which  0 denotes death and 1 denotes perfect health. The quality adjusted life year (QALY) can be obtained through multiplying the utility score and life expectancy. We estimated the QALY based on the treatments that patients received and the health conditions they are in. We assumed the condition of OHCA patients with cardiac causes is similar to those with acute myocardial infarction. In the model, the patients who were likely to have severe stenosis could receive invasive treatments, for example, percutaneous coronary intervention (PCI) and coronary artery bypass graft surgery (CABG). Patients who were likely to have mild or no stenosis would receive conservative medical treatment only. Thus, the estimates of one-year quality-of-life for the model were based on the research of unstable angina myocardial infarction ADDIN EN.CITE 27-29. The QALY after late PCI or CABG procedure for patients with severe stenosis were obtained from Kim et al. ADDIN EN.CITE 27 And the QALY after immediate PCI or CABG procedure for patients with severe stenosis were obtained from the study of Cohen et al. ADDIN EN.CITE 29 QALY after conservative treatment for patients with mild or severe stenosis were derived from Josephine et al30 and Mark et al31 respectively. 
2.5.3	Costs
We derived cost estimates from published literature. We estimated the cost of base conservative treatment, base invasive treatment, ECG test, angiography procedure, PCI procedure and CABG procedure from Aasa’s paper. ADDIN EN.CITE 32 Recalculation was conducted to estimate the cost of patients based on the treatment they received and health conditions they are in. More details of cost are in Table 1. All costs were adjusted to 2015 US dollars using the medical care component of the Consumer Price Index.33  We included the cost of initial hospitalization and cost of 1-year follow-up into our model. In the initial hospitalization cost, the procedure cost, hospital stay and physician fees were incorporated. In the 1-year follow-up cost, we estimated the cost of re-hospitalization, out-patient care, medications and physician fees.

Table 1. Base case estimates and ranges
	Base Case Estimate	          Range	Reference 	Notes
Probability values                                                                                                                                                     
Sensitivity of ECG ST-Elevation for diagnosis of artery occlusions	0.56	0.45-0.69	(25)	α= 9.02; β=7.09
Specificity of ECG ST-Elevation for diagnosis of artery occlusions	0.95	0.81-0.98	( ADDIN EN.CITE 15)	α=5.30 ; β=0.28
Prevalence of having >50% stenosis among general population	0.70	0.59-0.80*	( ADDIN EN.CITE 15)	α=12.63; β=5.41
Probability of having PCI given patients having ECG ST-Elevation	0.74	0.63-0.85*	( ADDIN EN.CITE 15)	α=11.03; β=3.87
Probability of having PCI given patients having >50% stenosis found by immediate angiography	0.58	0.49-0.67*	( ADDIN EN.CITE 15)	α=16.9; β=12.21
Probability of having PCI given patients having No ECG ST-Elevation	0.375	0.32-0.43*	(26)	α=29.2; β=47.67
Probability of having CABG given patients having ECG ST-Elevation	0.67	0.57-0.77*	(25)	α=14.14; β=6.97
Probability of having CABG given patients having No ECG ST-Elevation	0.65	0.55-0.75*	(26)	α=14.14; β=7.61
Cost ($)                                                                                                                                                            				
Cost of base conservative treatment	26,729	21,383-32,074*	( ADDIN EN.CITE 32)	µ=10.18; σ=0.19
Cost of base invasive treatment	22,617	18,094-27,141*	( ADDIN EN.CITE 32)	µ=10.01; σ=0.20
Cost of ECG test 	1,671	1,337-2,005*	( ADDIN EN.CITE 32)	µ =7.40; σ =0.20
Cost of angiography	1,330	1,064-1,596*	( ADDIN EN.CITE 32)	µ =7.17; σ =0.20
Cost of PCI procedure	5,066	4,053-6,079*	( ADDIN EN.CITE 32)	µ =8.51; σ =0.20
Cost of CABG procedure	10,701	8,561-12,841*	( ADDIN EN.CITE 32)	µ =9.26; σ =0.20

Table 1. (continued) Base case estimates and ranges
	Base Case Estimate	Range	Reference	Notes
Effectiveness (QALY)				
1-yr QALY for who underwent immediate PCI with Severe Stenosis	0.82	0.700.94	( ADDIN EN.CITE 29)	α=7.59; β =1.67
1-yr QALY for who underwent immediate CABG with Severe Stenosis	0.8	0.68-0.92*	( ADDIN EN.CITE 29)	α =0.09; β =2.02
1-yr QALY for who underwent late PCI with Severe Stenosis	0.70	0.60-0.81*	(34)	α=12.63; β=5.41
1-yr QALY for who underwent late CABG with Severe Stenosis	0.643	0.55-0.740*	(34)	α=15.71; β=8.72
1-yr QALY for who underwent conservative treatment with Mild Stenosis	0.756	0.64-0.87	( ADDIN EN.CITE 32)	α =9.79; β =3.16
1-yr QALY for who underwent conservative treatment with Severe Stenosis	0.6	0.51-0.69	(31)	α=17.2; β=11.45
The base case value means the best estimate for each variable. Unless otherwise noted, ranges are defined by 95% confidence intervals.* The range are estimated from 80% to 120%
3.0 	RESULTS
3.1	Base case analysis
Immediate angiography strategy was more effective (+0.03 QALY) and less expensive (-$1,281/year). Thus, the Immediate Angiography strategy is dominant in base case analysis in the condition of $100,000/QALY willingness-to-pay. (Table 2)





Note: Incr Cost: incremental cost; Eff: effectiveness; Incr eff: incremental effectiveness; NMB: net monetary benefit; INMB: incremental net monetary benefit.
3.2	Sensitivity Analysis
One-way sensitivity analysis showed that no parameters in the model had significant impact on the result. We plotted the Tornado diagram using incremental net monetary benefit (Figure 3, immediate angiography vs. standard care).  Net monetary benefit is equals to the difference between cost and the product of willingness-to-pay and effect (NMB = λ * Effect - Cost). The positive results of INMB favors immediate angiography. The “Sensitivity of ECG ST-segment elevation for diagnosis of acute myocardial infarction” has the largest effect on choosing favorable strategy. The one-way sensitivity analysis showed that the result of the base case analysis is robust within the range of all parameters.










Figure 3. Probabilistic sensitivity analysis (PSA)

4.0 	DISCUSSION
This cost-effectiveness analysis compares immediate angiography to standard care. The findings indicate that the immediate angiography strategy may improve both survival and neurological outcomes of the patients resuscitated from OHCA, but cost less than the standard care strategy. This is consistent with Dumas et al ADDIN EN.CITE 15 found in a randomized clinical trial in Paris. Because few studies have demonstrated whether the immediate angiography is cost effective in the United States, there is uncertainty about the cost estimates. Previous studies have used markov models. ADDIN EN.CITE 35 However, we chose a decision-tree model with 1-year time horizon because we believe that for patients with OHCA, most of cost and effectiveness could be included in a short-term period because of the low discharge survival rate. ADDIN EN.CITE 1 In the base case analysis, we found out immediate angiography is favorable with a $47,513 NMB in a condition of $100,000/QALY threshold. In the one-way sensitivity analysis, immediate angiography was favored within the ranges of all variables. It indicates that the result is robust. Currently, National Institute for Health and Care Excellence (NICE) recommends further drug treatment for the patients with unstable angina and NSTEMI first (Non-ST-Elevation Myocardial Infraction) (Appendix C), then decide when to offer coronary angiography. However, those assessments are subjective and finally it recommends revascularization strategies (PCI or CABG) based on the angiography results. The decision process and treatment procedures used in our model are similar to NICE’s, while we are planning to do invasive interventions for those with larger than 50% culprit lesions immediately. Both algorithms in NICE and our model demonstrated the significance of implementing coronary angiography in myocardial infarction with either ST-segment elevation or non-ST-segment elevation. 
Prior research has reported the comparisons between non-invasive diagnostic strategies, for example, exercise echocardiography and exercise ECG. ADDIN EN.CITE 35 The OHCA patients who were resuscitated, could be in coma, under this circumstance, ECG and other non-invasive strategies could not be appropriate to diagnose the etiology. Ollendorf et al36 found that angiography could provide better diagnosis than the ECG test, especially in emergent setting. Furthermore, angiography has been regarded as gold standard in diagnosing arterial lesions and because of the high prevalence of coronary occlusions and difficulties in interpreting the ECG results in the OHCA patients, immediate angiography should be considered as the first choice for diagnostic and treatment strategy.37 Abraham et al38 found that aggressive catheterization was performed in patients with non-cardiac causes of ST-segment elevation on ECG. He emphasized the inessentiality of pushing every cardiac arrest patient to the catheterization laboratory without appropriate evaluations. 
However, Abraham did not define what were the appropriate evaluations. Abraham did state an issue that the result of ECG alone cannot be used to determine the arterial lesions.  In the base case results of our analyses, immediate angiography strategy was dominant, which means it costs less but benefits more for the OHCA patients than the standard care strategy. In the acceptability curve, as the willingness-to-pay (WTP) increases, the probability of immediate angiography being cost effective decreases.  This could be caused by the distribution properties in the Monte Carlo simulation. As the WTP increases, the increase rate of becoming cost-effective is lower than the decrease rate of becoming non cost-effective.
There are several limitations in our research. For the model structure, we built a 1-year time horizon decision tree model, but Markov model could involve more details of the disease pattern and healthcare outcomes. For example, the recurrence in the long-term time horizon could affect the quality of life (QoL) and then affect the quality adjusted life-years (QALY). As what we stated above, short-term time horizon could involve major details of both strategies. Even though long-term time horizon model, like Markov model will reflect more information, the essentiality of it in our research needs to be discussed. 
In the analysis, we used secondary data from extant published literature and checked the reliability with other professionals, like the physicians and other modelers. The results of the sensitivity analysis of costs showed that none of them had a significant impact on our conclusions. Nonetheless, the property of the secondary data could affect the credibility and reliability of the model. In the future, we will conduct micro-costing analysis for obtaining more accurate data on cost. When conducting the literature review, we assumed that the condition of OHCA patients due to cardiac causes are like the myocardial infarction (MI) patients since MI is the major cause of cardiac arrest. ADDIN EN.CITE 4,5 Since other non-cardiac causes are easily excluded, like, drowning, asphyxia and falls, and brain-related causes can be diagnosed in a relative short time based on the disease history of the patient, we thought this assumption is reasonable and acceptable. 
From the research, we found out that applying the new immediate angiography has the potential of lowering the cost of treatment of OHCA. In 2010, the annual direct and indirect cost of treatment of cardiovascular disease (CVD) in the U.S. was 107.2 billion dollars. ADDIN EN.CITE 1 Considering the annual number of individuals suffering from the out-of-hospital cardiac arrest, the new immediate angiography strategy could help control lower the cost of treatment of cardiovascular disease. Additionally, based on previous research and our study, immediate angiography can improve healthcare outcomes, like survival and neurological functions. Among the developed countries, the healthcare system in the United States did not provide the benefit it should have provided for the public.39 Since 1974, the mortality rate decreased less in the US than it did in Australia, however, the healthcare cost increased faster. We believe that one of the major reasons is the unreasonable distribution of healthcare resources. We should apply new technology, strategy and management to help reallocate the limited healthcare resources. 
In the future, we are going to build a discrete states model, like Markov model, to include more details and assess whether the conclusion in this study is robust. Since the new immediate angiography strategy is cost effective, it is reasonable to conduct a budget impact analysis (BIA) to determine how the new immediate strategy influences the budgets in the local, state and federal level of US government. 
This study provides an evidence for modifying the current treatment strategy of OHCA. In conclusion, based on our modeling and simulation results, the strategy of immediate angiography is more effective and less costly than standard care for the diagnosis and treatment of out-of-hospital cardiac arrest patients.
5.0 	CONCLUSION




APPENDIX A: DISTRIBUTION PARAMETERS CALCULATION
For the Beta distribution, we calculated parameters through the equations of mean and standard deviation (mean = α/(α+β); variance = αβ/((α+β)2 * (α+β+1))). And we followed the similar procedures but with equations of mean = e(μ+σ^2/2) and variance = (e(σ^2 )-1) * e(2μ+σ^2) for Log-normal distribution. The calculation was perfumed through WolframAlpha website. we regarded the base case estimation as the mean and the range of every variable has ±2 standard deviations. For those not providing range of the values, we made estimation from 80% to 120% of variables.
APPENDIX B: INCREMENTAL COST-EFFECTIVENESS PLOT REPORTS








APPENDIX C: MANAGEMENT STRATEGIES FROM NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)
Early management of unstable angina and NSTEMI: https://pathways.nice.org.uk/pathways/chest-pain/early-management-of-unstable-angina-and-nstemi#content=view-node%3Anodes-intermediate-high-or-highest-risk (​https:​/​​/​pathways.nice.org.uk​/​pathways​/​chest-pain​/​early-management-of-unstable-angina-and-nstemi" \l "content=view-node%3Anodes-intermediate-high-or-highest-risk​)

Myocardial infarction with ST-segment elevation: acute management: https://www.nice.org.uk/guidance/cg167/chapter/1-Recommendations (​https:​/​​/​www.nice.org.uk​/​guidance​/​cg167​/​chapter​/​1-Recommendations​)

Chest pain overview: https://pathways.nice.org.uk/pathways/chest-pain (​https:​/​​/​pathways.nice.org.uk​/​pathways​/​chest-pain​)
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